Caveat mTOR: aberrant signaling disrupts corticogenesis.

Abstract excerpt

The mammalian target of rapamycin (mTOR) signaling pathway is activated in several disorders associated with benign tumors and malformations of the cerebral cortex. In this issue of the JCI, Orlova et al. have now definitively added another disorder to this group by demonstrating that activation of mTOR signaling is associated with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE), which is...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adaptor Proteins, Vesicular Transport
• Share to Cell Movement
• Share to Epilepsy